120 related articles for article (PubMed ID: 1724726)
1. Chemical semisynthesis of aprotinin homologues and derivatives mutated in P' positions.
Groeger C; Wenzel HR; Tschesche H
J Protein Chem; 1991 Oct; 10(5):527-33. PubMed ID: 1724726
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic semisynthesis of aprotinin homologues mutated in P' positions.
Groeger C; Wenzel HR; Tschesche H
J Protein Chem; 1991 Apr; 10(2):245-51. PubMed ID: 1718310
[TBL] [Abstract][Full Text] [Related]
3. Preparation of chemically 'mutated' aprotinin homologues by semisynthesis. P1 substitutions change inhibitory specificity.
Beckmann J; Mehlich A; Schröder W; Wenzel HR; Tschesche H
Eur J Biochem; 1988 Oct; 176(3):675-82. PubMed ID: 2458925
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic fragment substitution as a tool in protein design.
Tschesche H; Groeger C; Wenzel HR
Biomed Biochim Acta; 1991; 50(10-11):S175-80. PubMed ID: 1726455
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic resynthesis of the "reactive site" bond in the modified aprotinin derivatives [seco-15/16]aprotinin and [Di-seco-15/16,39/40]aprotinin.
Schnabel E; Reinhardt G; Schröder W; Tschesche H; Wenzel HR; Mehlich A
Biol Chem Hoppe Seyler; 1988 Jun; 369(6):461-8. PubMed ID: 2462426
[TBL] [Abstract][Full Text] [Related]
6. Semisynthetic aprotinin derivatives with specific alterations at the reactive-site peptide bond can be used to study structure-function relationships.
Mehlich A; Beckmann J; Wenzel HR; Tschesche H
Biochim Biophys Acta; 1989 Jun; 996(1-2):23-9. PubMed ID: 2472174
[TBL] [Abstract][Full Text] [Related]
7. Binding of native and [homoserine lactone-52]-52,53-seco-bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor) to porcine pancreatic beta-kallikrein-B and bovine alpha-chymotrypsin: thermodynamic study.
Oddone R; Barra D; Amiconi G; Ascenzi P; Tarricone C; Bolognesi M; Bortolotti F; Menegatti E
J Mol Recognit; 1994 Mar; 7(1):39-46. PubMed ID: 7527234
[TBL] [Abstract][Full Text] [Related]
8. Design of an aprotinin variant with inhibitory activity against chymotrypsin and cathepsin G by recombinant DNA technology.
Brinkmann T; Tschesche H
Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():43-52. PubMed ID: 1698068
[TBL] [Abstract][Full Text] [Related]
9. Aprotinin derivatives with chromophoric leaving groups can be used as highly selective active-site titrants for serine proteinases and permit the determination of kinetic constants of enzyme-inhibitor complexes.
Mehlich A; Beckmann J; Wenzel HR; Tschesche H
Biochim Biophys Acta; 1988 Dec; 957(3):420-9. PubMed ID: 2461739
[TBL] [Abstract][Full Text] [Related]
10. Semisynthesis of Arg15, Glu15, Met15, and Nle15-aprotinin involving enzymatic peptide bond resynthesis.
Beckmann J; Mehlich A; Schröder W; Wenzel HR; Tschesche H
J Protein Chem; 1989 Feb; 8(1):101-13. PubMed ID: 2475133
[TBL] [Abstract][Full Text] [Related]
11. Replacement of lysine by arginine, phenylalanine and tryptophan in the reactive site of the bovine trypsin-kallikrein inhibitor (Kunitz) and change of the inhibitory properties.
Jering H; Tschesche H
Eur J Biochem; 1976 Jan; 61(2):453-63. PubMed ID: 129327
[TBL] [Abstract][Full Text] [Related]
12. Role of the S' subsites in serine protease catalysis. Active-site mapping of rat chymotrypsin, rat trypsin, alpha-lytic protease, and cercarial protease from Schistosoma mansoni.
Schellenberger V; Turck CW; Rutter WJ
Biochemistry; 1994 Apr; 33(14):4251-7. PubMed ID: 8155642
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities.
Scheidig AJ; Hynes TR; Pelletier LA; Wells JA; Kossiakoff AA
Protein Sci; 1997 Sep; 6(9):1806-24. PubMed ID: 9300481
[TBL] [Abstract][Full Text] [Related]
14. Substitutions at the P(1) position in BPTI strongly affect the association energy with serine proteinases.
Grzesiak A; Helland R; Smalås AO; Krowarsch D; Dadlez M; Otlewski J
J Mol Biol; 2000 Aug; 301(1):205-17. PubMed ID: 10926503
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of a pancreatic trypsin inhibitor homologue and a model inhibitor.
Tan NH; Kaiser ET
Biochemistry; 1977 Apr; 16(8):1531-41. PubMed ID: 300629
[TBL] [Abstract][Full Text] [Related]
16. Designed replacement of an internal hydration water molecule in BPTI: structural and functional implications of a glycine-to-serine mutation.
Berndt KD; Beunink J; Schröder W; Wüthrich K
Biochemistry; 1993 May; 32(17):4564-70. PubMed ID: 7683491
[TBL] [Abstract][Full Text] [Related]
17. BPTI backbone variants and implications for inhibitory activity.
Groeger C; Wenzel HR; Tschesche H
Int J Pept Protein Res; 1994 Aug; 44(2):166-72. PubMed ID: 7527015
[TBL] [Abstract][Full Text] [Related]
18. The pH dependence of the equilibrium constant KHyd for the hydrolysis of the Lys15-Ala16 reactive-site peptide bond in bovine pancreatic trypsin inhibitor (aprotinin).
Siekmann J; Wenzel HR; Matuszak E; von Goldammer E; Tschesche H
J Protein Chem; 1988 Oct; 7(5):633-40. PubMed ID: 2475132
[TBL] [Abstract][Full Text] [Related]
19. Recombinant aprotinin homologue with new inhibitory specificity for cathepsin G.
Brinkmann T; Schnierer S; Tschesche H
Eur J Biochem; 1991 Nov; 202(1):95-9. PubMed ID: 1718753
[TBL] [Abstract][Full Text] [Related]
20. The specificity of clostripain from Clostridium histolyticum. Mapping the S' subsites via acyl transfer to amino acid amides and peptides.
Ullmann D; Jakubke HD
Eur J Biochem; 1994 Aug; 223(3):865-72. PubMed ID: 8055964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
